Puma Biotechnology Inc.

PBYI | NASDAQ

Price Alert Chart Builder DCF Calculator

$9.92

+$0.33 (+3.44%)

Sep 22, 2026, 11:40 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $488.13M

Enterprise Value $399.04M

Beta 1.23

Average Volume 310.71K

Shares Outstanding (Diluted) 52.6M

Shares Change YoY 4.89%

Institutional Ownership 74.46%

Exchange NASDAQ

ISIN US74587V1070

Price Performance

Price Change 1M 3.1%

Price Change 3M 19.3%

Price Change 6M 51.5%

Price Change YTD 66.2%

Price Change 1Y 115.0%

Price Change 3Y 231.8%

Price Change 5Y 40.6%

1M CAGR (ann.) 7.6%

1Y CAGR (ann.) 112.2%

5Y CAGR (ann.) 6.2%

All-Time CAGR -2.6%

Valuation

PE Ratio 18.44

Forward PE 48.18

PEG Ratio -0.40

Forward PEG -0.38

PS Ratio 2.11

Forward PS 2.10

PB Ratio 3.52

P/FCF Ratio 8.63

P/Adj. FCF Ratio 10.27

P/OCF Ratio 11.84

EV/Sales 1.73

EV/EBIT 11.50

EV/EBITDA 8.37

EV/FCF 7.05

Earnings Yield 5.4%

FCF Yield 11.6%

Adj. FCF Yield 9.7%

Financial Health

Net Cash $89.08M

Total Debt $4.82M

Cash & Short-Term Investments $93.9M

Total Assets $192.74M

Current Ratio 2.91

Quick Ratio 2.64

Debt / Equity Ratio 0.03

Debt / EBITDA 0.10

Debt / FCF 0.09

OCF / Debt 11.74

Interest Coverage 8.65

Altman Z-Score -1.50

Piotroski F-Score 6

Margins & Profitability

Gross Profit Margin 74.8%

Operating Profit Margin 13.2%

EBITDA Margin 20.6%

Net Profit Margin 11.6%

FCF Margin 24.5%

Adj. FCF Margin 20.6%

SBC / Revenue 3.1%

SBC Impact (per share) -16.0%

Returns

Return on Assets 13.9%

Return on Equity 20.9%

Return on Invested Capital 18.2%

Return on Capital Employed 21.3%

Return on Tangible Assets 17.1%

Historical Growth (CAGR)

Revenue CAGR 3Y 0.2%

Revenue CAGR 5Y -1.9%

Revenue CAGR 10Y 6.8%

EPS CAGR 3Y 29.3%

EPS CAGR 5Y 244.2%

EPS CAGR 10Y 49.0%

FCF CAGR 3Y 71.0%

FCF CAGR 5Y 103.1%

FCF CAGR 10Y 111.8%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 1

EPS Growth Next 3Y -43.0%

Revenue Growth Next 3Y 0.0%

Earnings Date Nov 4, 2026

EPS Estimate (next Q) $0.11

EPS Growth Est (next Q) -47.6%

Revenue Est (next Q) $57.5M

Revenue Growth Est (next Q) 10.8%

Fair Value Estimates

Graham Number $5.64

Graham Upside -41.2%

Lynch Fair Value $13

Lynch Upside 35.6%

Price Target $6

Price Target Upside -37.4%

Cash Flow

Operating Cash Flow $56.56M

Free Cash Flow $56.57M

Adj. Free Cash Flow $47.54M

FCF Per Share $0.81

OCF Per Share $0.81

OCF/S Ratio 17.8%

Income Statement

Revenue $231.24M

Gross Profit $173.05M

Operating Income $30.44M

EBITDA $47.67M

Net Income $26.72M

EPS (Diluted) $0.52

Revenue / Employee $1.29M

Profit / Employee $149.26K

Employees 179